Altered levels of CSF proteins in patients with FTD, presymptomatic mutation carriers and non-carriers

Altered levels of CSF proteins in patients with FTD, presymptomatic mutation carriers and non-carriers

Abstract Background The clinical presentations of frontotemporal dementia (FTD) are diverse and overlap with other neurological disorders. There are, as of today, no biomarkers in clinical practice for diagnosing the disorders. Here, we aimed to find protein markers in cerebrospinal fluid (CSF) from...

Full description

Bibliographic Details
Main Authors: Julia Remnestål, Linn Öijerstedt, Abbe Ullgren, Jennie Olofsson, Sofia Bergström, Kim Kultima, Martin Ingelsson, Lena Kilander, Mathias Uhlén, Anna Månberg, Caroline Graff, Peter Nilsson
Format: Article
Language:English
Published: BMC 2020-06-01
Series:Translational Neurodegeneration
Subjects:
Frontotemporal dementia
Cerebrospinal fluid
Biomarkers
Proteomics
Antibody suspension bead array
Online Access:http://link.springer.com/article/10.1186/s40035-020-00198-y

Internet

http://link.springer.com/article/10.1186/s40035-020-00198-y

Similar Items